showed a trendp = 0.066
Locoregional recurrence showed a trend toward reduction (3.8% [5/132] vs. 9.4% [31/330], p = 0.066), whereas distant metastasis and overall mortality were similar between groups. 3.4.
Locoregional recurrence showed a trend toward reduction (3.8% [5/132] vs. 9.4% [31/330], p = 0.066), whereas distant metastasis and overall mortality were similar between groups. 3.4.
While the pathologically-driven high-risk group (n = 62) did not reach statistical significance (p = 0.328), a notable clinical trend was observed: none of the 18 patients (0.00%) who underwent pMRI experienced any recurrence, compared to an 11.36% (5/44) recurrence rate in those who did not receive pMRI.